Your browser doesn't support javascript.
loading
Gender-Affirming Mastectomy in Transmasculine Patients: Does Obesity Increase Complications or Revisions?
Rothenberg, Kara A; Gologorsky, Rebecca C; Hojilla, J Carlo; Tang, Annie; Cohan, Caitlin M; Beattie, Genna; Yokoo, Karen M.
Afiliación
  • Rothenberg KA; From the Department of Surgery, University of California San Francisco-East Bay, Oakland.
  • Gologorsky RC; From the Department of Surgery, University of California San Francisco-East Bay, Oakland.
  • Tang A; From the Department of Surgery, University of California San Francisco-East Bay, Oakland.
  • Cohan CM; From the Department of Surgery, University of California San Francisco-East Bay, Oakland.
  • Beattie G; From the Department of Surgery, University of California San Francisco-East Bay, Oakland.
  • Yokoo KM; Department of Plastic Surgery, Kaiser Permanente Northern California, Richmond, CA.
Ann Plast Surg ; 87(1): 24-30, 2021 07 01.
Article en En | MEDLINE | ID: mdl-33559996
BACKGROUND: Obesity can often be a barrier to gender-affirming top surgery in transmasculine patients because of concern for increased surgical site complications. STUDY DESIGN: All adult patients (N = 948) within an integrated health care system who underwent gender-affirming mastectomy from 2013 to 2018 were retrospectively reviewed to evaluate the relationship between obesity and surgical site complications or revisions. RESULTS: One third of patients (n = 295) had obese body mass index (BMI), and those patients were further stratified into obesity class I (BMI of 30-34.9 kg/m2, 9.4%), class II (BMI of 35-39.9 kg/m2, 8.9%), and class III (BMI of ≥40 kg/m2, 2.9%). A majority of patients across BMI categories underwent double incision surgery. There were no significant differences in complications or revisions between patients with obesity versus those with normal BMI, when BMI was treated as a categorical or continuous variable and when evaluating only patients who underwent double incision surgery. CONCLUSIONS: Obesity alone should not be considered a contraindication for gender-affirming mastectomy. Attention should be given to several modifiable risk factors identified in this study, including lesser incision surgical techniques, tobacco use, and testosterone use. Further research is needed to understand risks associated with the highest BMI (≥40 kg/m2) patients and to assess patient satisfaction with surgical outcome.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Cirugía de Reasignación de Sexo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Ann Plast Surg Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Cirugía de Reasignación de Sexo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Ann Plast Surg Año: 2021 Tipo del documento: Article